Beacon Financial Group Merck & Co., Inc. Transaction History

Beacon Financial Group

  • $944 Million
  • Q3 2025

A detailed history of Beacon Financial Group transactions in Merck & Co., Inc. stock. As of the latest transaction made, Beacon Financial Group holds 6,374 shares of MRK stock, worth $591,889. This represents 0.06% of its overall portfolio holdings.

Number of Shares
6,374
Previous 6,301 1.16%
Holding current value
$591,889
Previous $498,000 7.23%
% of portfolio
0.06%
Previous 0.06%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 07, 2025
BUY
$77.6 - $87.37 $5,664 - $6,378
73 Added 1.16%
6,374 $534,000
Q2 2025

Jul 09, 2025
SELL
$73.47 - $87.12 $25,787 - $30,579
-351 Reduced 5.28%
6,301 $498,000
Q1 2025

Apr 10, 2025
SELL
$83.01 - $101.02 $285,554 - $347,508
-3,440 Reduced 34.09%
6,652 $597,000
Q4 2024

Jan 29, 2025
SELL
$96.31 - $114.76 $518,147 - $617,408
-5,380 Reduced 34.77%
10,092 $1 Million
Q3 2024

Nov 12, 2024
SELL
$111.15 - $128.97 $77,916 - $90,407
-701 Reduced 4.33%
15,472 $1.76 Million
Q2 2024

Aug 06, 2024
SELL
$123.8 - $132.96 $119,838 - $128,705
-968 Reduced 5.65%
16,173 $2 Million
Q1 2024

May 07, 2024
SELL
$113.24 - $131.95 $50,391 - $58,717
-445 Reduced 2.53%
17,141 $2.26 Million
Q4 2023

Feb 23, 2024
SELL
$100.18 - $109.02 $57,202 - $62,250
-571 Reduced 3.14%
17,586 $1.92 Million
Q3 2023

Oct 16, 2023
SELL
$102.95 - $114.33 $86,580 - $96,151
-841 Reduced 4.43%
18,157 $1.98 Million
Q2 2023

Jul 20, 2023
SELL
$108.61 - $118.38 $37,904 - $41,314
-349 Reduced 1.8%
18,998 $2.16 Million
Q1 2023

Apr 14, 2023
SELL
$102.94 - $114.86 $853,166 - $951,959
-8,288 Reduced 29.99%
19,347 $2.18 Million
Q4 2022

Jan 19, 2023
SELL
$87.44 - $112.11 $37,336 - $47,870
-427 Reduced 1.52%
27,635 $3.07 Million
Q3 2022

Oct 13, 2022
BUY
$84.53 - $94.96 $3,972 - $4,463
47 Added 0.17%
28,062 $2.43 Million
Q2 2022

Jul 19, 2022
SELL
$83.49 - $94.64 $44,333 - $50,253
-531 Reduced 1.86%
28,015 $2.59 Million
Q1 2022

Apr 08, 2022
BUY
$73.51 - $82.4 $1.56 Million - $1.75 Million
21,223 Added 289.81%
28,546 $2.37 Million
Q4 2021

Jan 07, 2022
SELL
$72.28 - $90.54 $5,926 - $7,424
-82 Reduced 1.11%
7,323 $563,000
Q3 2021

Oct 13, 2021
BUY
$71.68 - $78.83 $7,526 - $8,277
105 Added 1.44%
7,405 $556,000
Q2 2021

Jul 26, 2021
BUY
$70.31 - $77.77 $120,300 - $133,064
1,711 Added 30.61%
7,300 $556,000
Q4 2020

Jan 15, 2021
BUY
$71.77 - $79.65 $99,114 - $109,996
1,381 Added 32.82%
5,589 $462,000
Q3 2020

Oct 13, 2020
BUY
$73.18 - $82.95 $3,439 - $3,898
47 Added 1.13%
4,208 $349,000
Q2 2020

Aug 05, 2020
BUY
$70.42 - $80.13 $3,168 - $3,605
45 Added 1.09%
4,161 $317,000
Q1 2020

Jun 29, 2020
SELL
$63.36 - $87.82 $30,729 - $42,592
-485 Reduced 10.54%
4,116 $317,000
Q3 2019

Oct 15, 2019
BUY
$76.08 - $82.93 $5,173 - $5,639
68 Added 1.5%
4,601 $381,000
Q2 2019

Jul 15, 2019
BUY
$69.84 - $81.59 $17,739 - $20,723
254 Added 5.94%
4,533 $380,000
Q1 2019

Apr 18, 2019
SELL
$69.58 - $79.36 $298,915 - $340,930
-4,296 Reduced 50.1%
4,279 $356,000
Q4 2018

Jan 16, 2019
BUY
$65.24 - $75.71 $6,784 - $7,873
104 Added 1.23%
8,575 $646,000
Q3 2018

Oct 10, 2018
BUY
$57.69 - $67.84 $230 - $271
4 Added 0.05%
8,471 $601,000
Q2 2018

Jul 11, 2018
SELL
$50.83 - $59.72 $34,818 - $40,908
-685 Reduced 7.48%
8,467 $514,000
Q1 2018

Apr 06, 2018
BUY
$50.96 - $59.23 $102,174 - $118,756
2,005 Added 28.05%
9,152 $499,000
Q4 2017

Jan 03, 2018
BUY
$51.62 - $61.64 $100,917 - $120,506
1,955 Added 37.65%
7,147 $402,000
Q3 2017

Oct 03, 2017
BUY
$58.67 - $63.13 $304,614 - $327,770
5,192
5,192 $332,000

Others Institutions Holding MRK

# of Institutions
3,878
Shares Held
1.9B
Call Options Held
30.1M
Put Options Held
27.7M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $235B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Beacon Financial Group Portfolio

Follow Beacon Financial Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Financial Group, based on Form 13F filings with the SEC.

News

Stay updated on Beacon Financial Group with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email